{"id":204123,"name":"CROHN'S & COLITIS FOUNDATION","slug":"crohns-colitis-foundation","state":"NY","country":"United States of America","description":"&#226;€‹Non-profit","totalSpending":500000,"filings":25,"yearlySpending":[{"year":2020,"income":60000},{"year":2021,"income":100000},{"year":2022,"income":130000},{"year":2023,"income":90000},{"year":2024,"income":30000},{"year":2025,"income":90000}],"issues":["HCR","BUD","MED","MMM"],"firms":["FAEGRE DRINKER BIDDLE & REATH LLP"],"lobbyists":["LAUREN BLOCH","VINCENT GIGLIERANO","NICHOLAS MANETTO","CHARLES PRITCHARD","NICHOLAS NASTASI"],"govEntities":["HOUSE OF REPRESENTATIVES","Natl Institutes of Health (NIH)","SENATE","Centers For Disease Control & Prevention (CDC)"],"sampleDescriptions":["Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD and therapy development at FDA; Issues pertaining to response to COVID-19; H.R. 2","Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD and therapy development at FDA; Issues pertaining to response to COVID-19; H.R. 2","Issues related to step therapy protocols; H.R. 2279, S.2546 - Safe Step Act","Fiscal Year 2021 Appropriations including support for medical research at NIH, public health activities at CDC, research funding at DoD, and therapy development at FDA; Issues pertaining to response t","Issues related to step therapy protocols; H.R. 2279, S.2546 - Safe Step Act"],"years":[2020,2021,2022,2023,2024,2025]}